Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies

Clinical trial NCT05694364 · COMPLETED

Trial details

NCT number: NCT05694364
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma Triple Negative Breast Cancer Malignancies

Start date: 2023-01-25
Primary completion: 2024-04-18
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.